In conclusion, our studies extend the known mechanisms by which metformin can exert its effects on gene expression in cancer cells, and demonstrate for the first time that metformin is able to directly impact cancer cell proliferation by altering DNA methylation via regulation of the H19/SAHH axis. The gene discussed is AHCY; the disease is cancer.